Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Clinical trial NCT01947998 · COMPLETED

Trial details

NCT number: NCT01947998
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Venous Thrombosis Pulmonary Embolism Atrial Fibrillation Acute Coronary Syndrome

Start date: 2011-12-22
Primary completion: 2020-09-30
Enrollment: 50299

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.